Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511]
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Redox Biology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231722003202 |
_version_ | 1811185515438800896 |
---|---|
author | Xing Luo Xiuzhu Weng Xiaoyi Bao Xiaoxuan Bai Ying Lv Shan Zhang Yuwu Chen Chen Zhao Ming Zeng Biyi Xu Thomas Johnson Stephen J. White Ji Li Haibo Jia Bo Yu |
author_facet | Xing Luo Xiuzhu Weng Xiaoyi Bao Xiaoxuan Bai Ying Lv Shan Zhang Yuwu Chen Chen Zhao Ming Zeng Biyi Xu Thomas Johnson Stephen J. White Ji Li Haibo Jia Bo Yu |
author_sort | Xing Luo |
collection | DOAJ |
first_indexed | 2024-04-11T13:30:43Z |
format | Article |
id | doaj.art-1637b00e628a43d2a872d274409c92fb |
institution | Directory Open Access Journal |
issn | 2213-2317 |
language | English |
last_indexed | 2024-04-11T13:30:43Z |
publishDate | 2022-12-01 |
publisher | Elsevier |
record_format | Article |
series | Redox Biology |
spelling | doaj.art-1637b00e628a43d2a872d274409c92fb2022-12-22T04:21:49ZengElsevierRedox Biology2213-23172022-12-0158102548Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511]Xing Luo0Xiuzhu Weng1Xiaoyi Bao2Xiaoxuan Bai3Ying Lv4Shan Zhang5Yuwu Chen6Chen Zhao7Ming Zeng8Biyi Xu9Thomas Johnson10Stephen J. White11Ji Li12Haibo Jia13Bo Yu14Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR ChinaDepartment of Cardiology, Bristol Heart Institute, Upper Maudlin St., Bristol, BS2 8HW, UKDepartment of Life Sciences, Manchester Metropolitan University, Manchester, M1 5GD, UKDepartment of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR China; Corresponding author. Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China.Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR China; Corresponding author. Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China.Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150001, PR Chinahttp://www.sciencedirect.com/science/article/pii/S2213231722003202 |
spellingShingle | Xing Luo Xiuzhu Weng Xiaoyi Bao Xiaoxuan Bai Ying Lv Shan Zhang Yuwu Chen Chen Zhao Ming Zeng Biyi Xu Thomas Johnson Stephen J. White Ji Li Haibo Jia Bo Yu Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511] Redox Biology |
title | Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511] |
title_full | Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511] |
title_fullStr | Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511] |
title_full_unstemmed | Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511] |
title_short | Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511] |
title_sort | corrigendum to a novel anti atherosclerotic mechanism of quercetin competitive binding to keap1 via arg483 to inhibit macrophage pyroptosis redox biol 57 2022 102511 |
url | http://www.sciencedirect.com/science/article/pii/S2213231722003202 |
work_keys_str_mv | AT xingluo corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT xiuzhuweng corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT xiaoyibao corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT xiaoxuanbai corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT yinglv corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT shanzhang corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT yuwuchen corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT chenzhao corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT mingzeng corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT biyixu corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT thomasjohnson corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT stephenjwhite corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT jili corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT haibojia corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 AT boyu corrigendumtoanovelantiatheroscleroticmechanismofquercetincompetitivebindingtokeap1viaarg483toinhibitmacrophagepyroptosisredoxbiol572022102511 |